EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumor‐type–specific expression of TTF ‐1 in primary central nervous system tumors classified by the 2021 WHO criteria

Lu Xu iD, Hong-Jiu Ren, Jian Gu, Bing-Wen Shan, Tong Ren, Chu-Hang Liu, Chun-Xian Cai, Xiao-Yu Zhang, Juan-Han Yu

The Journal of Pathology: Clinical Research · 2026-07 · 12 (4)

DOI: 10.1002/2056-4538.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 19.07.2026. Verfasst von Lu Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Hospital of China Medical University, Shenyang, PR China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Central Nervous System Neoplasms, Thyroid Nuclear Factor 1. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid transcription factor‐1 (TTF‐1) is a widely used immunohistochemical marker for tumors of thyroid and pulmonary origin; however, its expression profile and diagnostic relevance in primary central nervous system (CNS) tumors remain incompletely characterized, particularly following the revisions in the 2021 WHO Classification of CNS Tumors. We systematically evaluated TTF‐1 expression in a cohort of 214 primary CNS tumors diagnosed between 2021 and 2024 at The First Affiliated Hospital of China Medical University and classified according to current WHO criteria. Immunohistochemistry for TTF‐1 was performed, and expression patterns were correlated with histological tumor type, molecular classification, and WHO grade. Statistical analyses were conducted to compare expression frequencies across tumor subtypes. TTF‐1 showed tumor‐specific expression patterns. It was highly sensitive in central neurocytomas (89.47%) and fully specific for subependymal giant cell astrocytoma (SEGA) among circumscribed gliomas. Focal TTF‐1 positivity was sporadically detected in high‐grade diffuse gliomas, without significant links to molecular alterations, anatomical sites, or other common immunohistochemical indicators. TTF‐1 was consistently negative in multiple newly classified and rare CNS tumors, whereas partial intracranial mesenchymal tumors with FET–CREB fusions presented TTF‐1 positivity. In conclusion, TTF‐1 serves as a reliable sensitive marker for central neurocytomas and a highly specific marker for SEGA. Given its occasional positivity in high‐grade gliomas and certain intracranial mesenchymal tumors, pathologists should interpret TTF‐1 results prudently to avoid misdiagnosing primary CNS lesions as metastatic tumors. TTF‐1 is therefore a valuable auxiliary biomarker for difficult differential diagnosis of CNS tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCentral Nervous System NeoplasmsThyroid Nuclear Factor 1HumansFemaleWorld Health OrganizationMaleImmunohistochemistryAdultMiddle AgedAgedChildAdolescentYoung AdultGlioma

Stichwörter der Autor:innen

WHO classificationcentral nervous system tumorsdiagnostic pathologydiffuse gliomaneurocytomathyroid transcription factor‐1

Substanzen

Biomarkers, TumorThyroid Nuclear Factor 1NKX2-1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, The First Hospital of China Medical University, Shenyang, PR China.
  • Department of Pathology, College of Basic Medical Sciences of China Medical University, Shenyang, PR China.

ORCID-Profile: Lu Xu

Zitieren

APA

Xu, L., Ren, H. J., Gu, J., Shan, B. W., Ren, T., Liu, C. H., Cai, C. X., Zhang, X. Y., & Yu, J. H. (2026). Tumor‐type–specific expression of TTF ‐1 in primary central nervous system tumors classified by the 2021 WHO criteria. The Journal of Pathology: Clinical Research, 12(4). https://doi.org/10.1002/2056-4538.70109

Vancouver

Xu L, Ren HJ, Gu J, Shan BW, Ren T, Liu CH, et al. Tumor‐type–specific expression of TTF ‐1 in primary central nervous system tumors classified by the 2021 WHO criteria. The Journal of Pathology: Clinical Research. 2026;12(4). doi:10.1002/2056-4538.70109

BibTeX
@article{Xu2026,
  author = {Xu, Lu and Ren, Hong-Jiu and Gu, Jian and Shan, Bing-Wen and Ren, Tong and Liu, Chu-Hang and Cai, Chun-Xian and Zhang, Xiao-Yu and Yu, Juan-Han},
  title = {Tumor‐type–specific expression of TTF ‐1 in primary central nervous system tumors classified by the 2021 WHO criteria},
  journal = {The Journal of Pathology: Clinical Research},
  year = {2026},
  volume = {12},
  number = {4},
  doi = {10.1002/2056-4538.70109}
}
Kostenlos starten →